Summary
n-Hexyl-delta-8-tetrahydrocannabiol (n-hexyl-dclta-8-THC) andn-hexyl-delta-9-THC were synthesized by condensation of (1S)-cis-verbenol with 5-n-hexyl-1,3-dihydroxybenzene and administered intraperitoneally to male Charles-River CD-1 mice. Hepatic metabolites were isolated by solvent extraction and chromatography on Sephadex LH-20 and identified by GC/MS. Eleven metabolites were identified fromn-hexyl-delta-8-THC and sixteen fromn-hexyl-delta-9-THC. The pattern of metabolites was intermediate between that previously observed from the pentyl homologues and that fromn-heptyl-delta-9-THC with the major biotransformation pathway being hydroxylation and oxidation at Coli. Other metabolites were mainly hydroxylated derivatives of these compounds. Metabolites containing two hydroxy groups in the side-chain were present in low concentration. These have not been observed from lower homologues but are major metabolites ofn-heptyl-delta-9-THC. Compared with the metabolism of then-pentyl homologue, there was a trend towards the production of more hydroxy metabolites at the expense of carboxylic acids, in keeping with the general reduction of oxidation observed with other homologous cannabinoids as the chain length increases.
Similar content being viewed by others
References
Turner C.E., Elsohly M.A. Boeren E.G. (1980): Constituents of Cannabis sativa L., XVII: A review of the natural constituents. J. Nat. Prod., 43, 169–234.
Harvey D.J. (1976): Characterization of the butyl homologues of delta-1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry. J. Pharm. Pharmacol., 28. 280–285.
Harvey D.J. (1985): Examination of a 140 year old ethanolic extract of Cannabis: identification of new cannabitriol homologues and the ethyl homologue of cannabinol. In: Harvey D.J. ed., Marihuana ′84. Proceedings of the Oxford Symposium on Cannabis. Oxford. IRL Press. pp. 23–30.
Shoyama Y., Yagi M., Nishioka I., Yamauchi T. (1975): Biosynthesis of cannabinoid acids. Pytochemistry. 14, 2189–2192.
Razdan R.K. (1986): Structure-activity relationships in cannablnoids. Pharmacol. Rev., 38, 75–149.
Leuschner J.T.A. Wing D.R. Harvey D.J., Brent G.A. Dempsey C.E., Watts A., Paton W.D.M. (1984): The partitioning of delta-1-tetrahydrocannabinol into erythrocyte membranes. in vivo and its effect on membrane fluidity. Experientia. 40. 866–868.
Harvey D.J. (1985): Identification of hepatic metabolites of n-heptyl-delta-1-tetrahydrocannabinol in the mouse. Xenobiotica, 15, 187–197.
Harvey D.J., Paton W.D.M. (1984): Metabolism of the cannabinoids. Rev. Biochem. Toxicol., 6, 221–264.
Brown N.K., Harvey D.J. (1988): Biomed. Environ. Mass Spectrom., 15, 389–398.
Focella A, Teitel S., Brossi A. (1977): A simple and practical synthesis of olivetol. J. Org. Chem., 42, 3456–3457.
Suter C.M. Weston A.W. (1939): The synthesis and bactericidal properties of some 5-n-alkylresorcinols. J. Am. Chem. Soc., 61, 232–237.
Mechoulam R., Braun P., Gaoni Y. (1972): Synthesis of delta-1-tetrahydrocannabinol and related cannabinoids. J. Am. Chern. Soc., 94, 6159–6164.
Archer R.A., Boyd D.B., Demarco P.V., Tyminski I.J., Allinger N.L. (1970): Structural studies of cannabinoids. A theoretical and proton magnetic resonance analysis. J. Am. Chern. Soc., 92, 5200–5206.
Petrzilka T., Haefliger W., Sikemeier C. (1969): Synthese von Haschisch Inhaltsstoffen. Helv, Chim. Acta. 52, 1102–1134.
Harvey D.L. Martin B.R.. Paton W.D.M. (1977): Identification of di- and tri-substituted hydroxy and ketone metabolites of delta-1-tetrahydrocannabinol in mouse liver. J. Pharm. Pharmacol., 29, 482–486.
McCloskey J.A. Stillwell R.N., Lawson A.M. (1968): Use of deuterium-labelled trimethylsilyl derivatives in mass spectrometry. Anal. Chern. 40, 233–236.
Harvey D.J., Paton W.D.M. (1980): The use of deuterium labelling in structural and quantitative studies of tetrahydrocannabinol metabolites by mass spectrometry. Adv, Mass Spectrom., 8, 1194–1203.
Harvey D.J. (1981): The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of delta-1-and delta-6-tetrahydrocannabinol. Biomed. Mass Spectrom., 8, 579–588.
Harvey D.J. (1987): Mass spectrometry of the cannabinoids and their metabolites. Mass Spectrom. Rev., 6, 135–229.
Binder M., Agurell S., Leander K., Lindgren J.-E. (1974): Zur Identifikation potentieller Metabolite von Cannabis-Inhaltstoffen: Kernresonanz und Massenspektroskopische Untersuchungen an seitenketten-hydroxylierten Cannabinoiden. Helv. Chim. Acta. 57. 1626–1641.
Harvey D.J., Martin B.R., Paton W.D.M. (1977): In vivo metabolism of cannabinol by the mouse and rat and a comparison with the metabolism of delta-1-tetrahydrocannabinol and cannabidiol. Biomed. Mass Spectrom., 4, 364–370.
Harvey D.L. Paton W.D.M. (1980): Identification of in vivo liver metabolites of delta-6-tetrahydrocannabinol produced by the mouse. Drug Metah., Dispos., 8, 178–186.
Harvey D.J., Paton W.D.M. (1977): In vivo metabolites of delta-l(6)-tetrahydrocannabinol produced by the mouse via the epoxide — diol pathway. J. Pharm. Pharmacol., 29, 498–500.
Harvey D.J. (1981): The mass spectra of the trimethylsilyl derivatives of cis- and trans-hexahydrocannabinol and their hydroxy and acid analogues. Biomed. Mass Spectrom. 8, 366–372.
Powers P., Wallington M.J., Hopkinson. J.A.V., Keams. G.L. (1975): An extension to the role of the dedicated data system in GC-MS. Presented at the 23rd Annual Conference on Mass Spectrometry and Allied Topics. Houston. Texas. 25–30 May. American Society for Mass Spectrometry. Abstracts. pp. 499–502.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brown, N.K., Harvey, D.J. Metabolism of n-hexyl-homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse. European Journal of Drug Metabolism and Pharmacokinetics 13, 165–176 (1988). https://doi.org/10.1007/BF03189936
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189936